Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
Catechin-gallocatechin-catechin
Potential treatment - theoretical effect Natural product Antiviral Jan/21/2021
Quercimeritrin 6”-O-L-arabinopyranoside
Potential treatment - theoretical effect Natural product Antiviral Jan/07/2021
Ergosterol
Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021
Karuquinone B
Potential treatment - theoretical effect Natural product Antiviral Nov/16/2020
4-(3-Phenylacryloyloxymethyl)-6,7-dimethoxycoumarin
Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021
Thiamine
Potential treatment - theoretical effect Natural product Antiviral Dec/10/2020
Gummadiol
Potential treatment - theoretical effect Natural product Antiviral Jul/17/2020
Quercetagetin
Potential treatment - theoretical effect Natural product Antiviral Jan/12/2021
25-hydroxycholesterol 
Potential treatment - pre-clinical evidence Natural product Antiviral Nov/25/2020
KFVPKQPNMIL
Potential treatment - theoretical effect Natural product Antiviral Dec/11/2020
Bilobetin
Potential treatment - theoretical effect Natural product Antiviral Nov/03/2020
Amentoflavone
Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021
Withanolide A
Potential treatment - theoretical effect Natural product Antiviral Nov/05/2020
Ginkgetin
Potential treatment - theoretical effect Natural product Antiviral Nov/03/2020
Taxifolin
Potential treatment - theoretical effect Natural product Antiviral Nov/25/2020
Orientin
Potential treatment - theoretical effect Natural product Antiviral Jan/11/2021
(S)-5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one
Potential treatment - theoretical effect Natural product Antiviral Dec/30/2020
Kaempferol
Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021
Lariciresinol
Potential treatment - theoretical effect Natural product Antiviral Oct/06/2020
Breast milk
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/01/2021